Laricifomes officinalis
The Ancient Guardian — World's Longest-Living Mushroom
75–100 yrs
Lifespan
65 AD
First Documented
Critically rare
Conservation Status
BioShield
Defense Research
Agarikon is the longest-living mushroom species known to science, with individual specimens estimated to live for 75–100 years. It grows exclusively on old-growth conifers in the temperate rainforests of the Pacific Northwest, Europe, and formerly across much of the Northern Hemisphere. Now critically rare due to old-growth deforestation, Agarikon has been called the 'elixir of long life' since the time of the ancient Greeks. Mycologist Paul Stamets has championed its conservation and research, identifying it as a potential source of novel antiviral compounds.
Agarikon is one of the oldest documented medicinal mushrooms in Western history. The Greek physician Dioscorides described it in 'De Materia Medica' (65 AD) — one of the foundational texts of Western pharmacology — as a treatment for 'consumption' (tuberculosis) and respiratory ailments. It was used extensively throughout European herbal medicine for over 2,000 years before its habitat was largely destroyed by industrial logging. Indigenous peoples of the Pacific Northwest, including the Tlingit, used Agarikon for spiritual ceremonies and as medicine for coughs and infections.
Contains novel antiviral compounds under active research
Supports respiratory health and lung function
Historical use spanning 2,000+ years in Western medicine
May support the body's defenses against seasonal challenges
Antimicrobial properties documented in laboratory studies
Supports immune resilience in traditional use
Bioactive Compound Profile
Novel compounds not found in any other mushroom species. Under investigation for antiviral and antimicrobial properties in defense-funded research programs.
A long-chain fatty acid historically associated with Agarikon's traditional respiratory uses. Exhibits mild antimicrobial activity.
Immune-modulating polysaccharides that activate innate immune pathways.
Multiple terpenoid compounds contributing to antimicrobial and anti-inflammatory activity.
Vitamin D2 precursor present in the fruiting body.
Paul Stamets and colleagues at Fungi Perfecti have spearheaded modern Agarikon research, screening strains against various viral pathogens. In 2005, Stamets' research team demonstrated that certain Agarikon strains exhibited significant activity against multiple viral challenges in laboratory settings, including some of the strongest responses observed among all mushroom species tested. This research, conducted in partnership with the U.S. Department of Defense's BioShield program, identified chlorinated coumarins and other novel compounds. A 2019 review in Mycologia highlighted Agarikon's unique chemistry and urgent conservation status.
*These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before starting any supplement regimen.